194796-50-4

Upstream product

• 1026417-67-3 (1R,4S,4aR,5S,8aS)-5,8-Bis-(tert-butyl-dimethyl-silanyloxy)-1,4,4a,5,6,8a-hexahydro-1,4-methano-naphthalene 
• 194796-37-7 C₁₂H₁₅BrO 
• 194796-35-5 C₁₂H₁₅BrO 
• 173201-02-0 (+)-(1R,4S,4aR,5S,8aS)-1,4,4a,6,7,8a-hexahydro-5-hydroxy-endo-1,4-methanonaphthalen-8(5H)-one 
• 194796-44-6 (1R,4S,4aR,8R,8aS)-8-Methyl-4,4a,6,7,8,8a-hexahydro-1H-1,4-methano-naphthalen-5-one 
• 194796-33-3 (1R,4S,4aR,5S,8aS)-8-Methylene-1,4,4a,5,6,7,8,8a-octahydro-1,4-methano-naphthalen-5-ol 
• 194796-41-3 (1R,4S,4aR,5S,8R,8aS)-8-Methyl-1,4,4a,5,6,7,8,8a-octahydro-1,4-methano-naphthalen-5-ol 
• 194796-39-9 C₁₂H₁₇BrO 
• 194796-30-0 (+)-(1R,4S,4aR,5S,8aS)-5-tert-Butyldimethylsilyloxy-1,4,4a,6,7,8-hexahydro-endo-1,4-methanonaphthalen-8(5H)-one 
• 39691-62-8 nonylmagnesium bromide 
• 194796-47-9 (1R,4S,4aR,5S,8R,8aS)-8-Methyl-5-nonyl-1,4,4a,5,6,7,8,8a-octahydro-1,4-methano-naphthalen-5-ol 

Relevant academic research and scientific papers

A new tactic for diastereo- and enantiocontrolled synthesis of (-)-malyngolide via catalytic meso-asymmetrization

A meso-1,4-enediol bis-silyl ether 2 having bicyclo[2.2.1]heptene background has been transformed diastereo- and enantioselectively into (-)malyngolide 1, an antibiotic isolated from the blue-green marine algae, Lyngbya majuscula, via Rh(I)-(R)BINAP-catalyzed asymmetrization and diastereoselective modification of the optically active product thus obtained.